IRIDEX Return on Tangible Equity 2010-2023 | IRIX
Current and historical return on tangible equity values for IRIDEX (IRIX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| IRIDEX Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-12-31 |
$-0.01B |
$0.01B |
-100.00% |
| 2023-09-30 |
$-0.01B |
$0.01B |
-68.09% |
| 2023-06-30 |
$-0.01B |
$0.01B |
-60.38% |
| 2023-03-31 |
$-0.01B |
$0.01B |
-48.28% |
| 2022-12-31 |
$-0.01B |
$0.01B |
-44.44% |
| 2022-09-30 |
$-0.01B |
$0.02B |
-46.38% |
| 2022-06-30 |
$-0.01B |
$0.02B |
-42.11% |
| 2022-03-31 |
$-0.01B |
$0.02B |
-23.81% |
| 2021-12-31 |
$-0.01B |
$0.02B |
-22.73% |
| 2021-09-30 |
$-0.00B |
$0.02B |
-14.12% |
| 2021-06-30 |
$-0.00B |
$0.02B |
-15.00% |
| 2021-03-31 |
$-0.01B |
$0.02B |
-37.84% |
| 2020-12-31 |
$-0.01B |
$0.02B |
-38.36% |
| 2020-09-30 |
$-0.01B |
$0.02B |
-46.15% |
| 2020-06-30 |
$-0.01B |
$0.02B |
-42.86% |
| 2020-03-31 |
$-0.01B |
$0.02B |
-35.16% |
| 2019-12-31 |
$-0.01B |
$0.02B |
-37.11% |
| 2019-09-30 |
$-0.01B |
$0.02B |
-38.46% |
| 2019-06-30 |
$-0.01B |
$0.03B |
-38.94% |
| 2019-03-31 |
$-0.01B |
$0.03B |
-42.86% |
| 2018-12-31 |
$-0.01B |
$0.03B |
-46.43% |
| 2018-09-30 |
$-0.02B |
$0.03B |
-53.10% |
| 2018-06-30 |
$-0.02B |
$0.02B |
-52.17% |
| 2018-03-31 |
$-0.02B |
$0.03B |
-46.88% |
| 2017-12-31 |
$-0.01B |
$0.03B |
-37.14% |
| 2017-09-30 |
$-0.02B |
$0.03B |
-51.35% |
| 2017-06-30 |
$-0.02B |
$0.04B |
-45.95% |
| 2017-03-31 |
$-0.01B |
$0.04B |
-38.62% |
| 2016-12-31 |
$-0.01B |
$0.04B |
-34.53% |
| 2016-09-30 |
$-0.00B |
$0.03B |
-2.99% |
| 2016-06-30 |
$0.00B |
$0.03B |
0.00% |
| 2016-03-31 |
$-0.00B |
$0.03B |
-3.08% |
| 2015-12-31 |
$-0.00B |
$0.03B |
-3.08% |
| 2015-09-30 |
$0.01B |
$0.03B |
24.62% |
| 2015-06-30 |
$0.01B |
$0.03B |
26.02% |
| 2015-03-31 |
$0.01B |
$0.03B |
31.03% |
| 2014-12-31 |
$0.01B |
$0.03B |
33.03% |
| 2014-09-30 |
$0.00B |
$0.03B |
0.00% |
| 2014-06-30 |
$0.00B |
$0.03B |
4.00% |
| 2014-03-31 |
$0.00B |
$0.03B |
4.08% |
| 2013-12-31 |
$0.00B |
$0.03B |
8.51% |
| 2013-09-30 |
$0.00B |
$0.02B |
8.89% |
| 2013-06-30 |
$0.00B |
$0.02B |
0.00% |
| 2013-03-31 |
$0.00B |
$0.02B |
0.00% |
| 2012-12-31 |
$0.00B |
$0.02B |
4.40% |
| 2012-09-30 |
$0.00B |
$0.02B |
8.79% |
| 2012-06-30 |
$0.00B |
$0.02B |
13.79% |
| 2012-03-31 |
$0.00B |
$0.02B |
19.51% |
| 2011-12-31 |
$0.00B |
$0.02B |
15.58% |
| 2011-09-30 |
$0.00B |
$0.02B |
16.22% |
| 2011-06-30 |
$0.00B |
$0.02B |
22.54% |
| 2011-03-31 |
$0.00B |
$0.02B |
23.88% |
| 2010-12-31 |
$0.00B |
$0.02B |
18.75% |
| 2010-09-30 |
$0.00B |
$0.02B |
20.00% |
| 2010-06-30 |
$0.00B |
$0.02B |
21.05% |
| 2010-03-31 |
$0.00B |
$0.02B |
22.22% |
| 2009-12-31 |
$0.00B |
$0.01B |
24.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.046B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
